FDA to Validate FSV Email Syntax on 9/4/21

CSMS #48912861 - FDA to Validate FSV Email Syntax on 9/4/21 U.S. Customs and Border Protection sent this bulletin at 07/28/2021 09:45 AM EDT CSMS #48912861 - FDA to Validate FSV Email Syntax on 9/4/21 On September 4, 2021 the U.S. Food and Drug Administration (FDA) will deploy validation to check the syntax of the email transmitted in PG21 for the FSV entity.  This enhancement is the result of a high volume of entry lines received with an invalid syntax. The Foreign Supplier Verification Programs (FSVP) regulation requires the FSVP Importer email to be transmitted. Filers should verify the FSV email address transmitted on each entry line is valid immediately and not wait for this enhancement in order to avoid rejects when deployed. Only transmit one valid email address as you would in an email program. Do not include names, additional characters, etc. that are not part of the valid email address. Valid Example first.last@company.com Invalid Example               Invalid Example               FirstName LastName first.last@company.com Invalid Example               FirstName LastName Invalid Example first.last@company.com , first.last@company.com This information and examples will be added to the next version of the FDA ACE Supplemental Guide. For questions regarding FDA ACE requirements contact FDA ACE Support 8AM-8PM ET, Monday-Friday: ACE_Support@fda.hhs.gov ; 877-345-1101.